Strengths, weaknesses, opportunities, and threats (SWOT) of the electronic prescribing systems executed in Iran from the physician's viewpoint: a qualitative study.
Electronic prescribing
Information system
Qualitative research
Technology
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
30 Sep 2024
30 Sep 2024
Historique:
received:
02
02
2023
accepted:
17
09
2024
medline:
1
10
2024
pubmed:
1
10
2024
entrez:
1
10
2024
Statut:
epublish
Résumé
Electronic prescribing (e-prescribing) is an essential technology in the modern health system. This technology has made many changes in the prescription process, which have advantages and disadvantages and have created opportunities for transforming the health system. This study aimed to investigate the strengths, weaknesses, opportunities, and threats of the e-prescribing system implemented in Iran from the physician's viewpoint. This phenomenological qualitative study was conducted in 2022. The participants were 15 Iranian specialist physicians working at Urmia University of Medical Sciences, selected purposively and deliberately. Data was collected through in-depth semi-structured interviews using an interview guide comprising 16 questions. Interviews were conducted until data saturation was reached. The audio data was transcribed into text and analyzed using the thematic analysis. To ensure the validity and reliability of the findings, the criteria introduced by Lincoln and Guba were employed. The results of this study showed that the e-prescribing system executed in Iran has diverse and multidimensional strengths, weaknesses, opportunities, and threats. In the strengths section, the analysis of the interviews led to the extraction of semantic units in the categories of prescription process, prescriber, patient, technical, economic, communication, and insurance. Also, the weaknesses in the three categories of the prescriber, patient, and technical were debatable. The opportunities extracted from the narratives of the interviewees were placed in four categories including technical, national macro policies, Ministry of Health macro-policies, and socio-cultural issues. Finally, the discussed threats are classified into two technical and macro policies of the Ministry of Health categories. On the other hand, technical issues played an effective role in all aspects of the SWOT model. The e-prescribing system in Iran has strengths, weaknesses, opportunities, and threats. An overarching factor across all aspects of the SWOT model was technical infrastructure. A robust technical infrastructure is considered a strength and an opportunity for the growth of the electronic prescribing system in Iran. Conversely, any shortcomings in these systems are viewed as weaknesses and pose a threat to the system's sustainability.
Sections du résumé
BACKGROUND
BACKGROUND
Electronic prescribing (e-prescribing) is an essential technology in the modern health system. This technology has made many changes in the prescription process, which have advantages and disadvantages and have created opportunities for transforming the health system. This study aimed to investigate the strengths, weaknesses, opportunities, and threats of the e-prescribing system implemented in Iran from the physician's viewpoint.
METHODS
METHODS
This phenomenological qualitative study was conducted in 2022. The participants were 15 Iranian specialist physicians working at Urmia University of Medical Sciences, selected purposively and deliberately. Data was collected through in-depth semi-structured interviews using an interview guide comprising 16 questions. Interviews were conducted until data saturation was reached. The audio data was transcribed into text and analyzed using the thematic analysis. To ensure the validity and reliability of the findings, the criteria introduced by Lincoln and Guba were employed.
RESULTS
RESULTS
The results of this study showed that the e-prescribing system executed in Iran has diverse and multidimensional strengths, weaknesses, opportunities, and threats. In the strengths section, the analysis of the interviews led to the extraction of semantic units in the categories of prescription process, prescriber, patient, technical, economic, communication, and insurance. Also, the weaknesses in the three categories of the prescriber, patient, and technical were debatable. The opportunities extracted from the narratives of the interviewees were placed in four categories including technical, national macro policies, Ministry of Health macro-policies, and socio-cultural issues. Finally, the discussed threats are classified into two technical and macro policies of the Ministry of Health categories. On the other hand, technical issues played an effective role in all aspects of the SWOT model.
CONCLUSION
CONCLUSIONS
The e-prescribing system in Iran has strengths, weaknesses, opportunities, and threats. An overarching factor across all aspects of the SWOT model was technical infrastructure. A robust technical infrastructure is considered a strength and an opportunity for the growth of the electronic prescribing system in Iran. Conversely, any shortcomings in these systems are viewed as weaknesses and pose a threat to the system's sustainability.
Identifiants
pubmed: 39350196
doi: 10.1186/s12911-024-02687-w
pii: 10.1186/s12911-024-02687-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279Informations de copyright
© 2024. The Author(s).
Références
Rosa MB, Nascimento MMGd, Cirilio PB, Santos RA, Batista LF, Perini E, Couto RC. Electronic prescription: frequency and severity of medication errors. Rev Assoc Med Bras. 2019;65:1349–55.
doi: 10.1590/1806-9282.65.11.1349
pubmed: 31800895
Samadbeik M, Ahmadi M, Sadoughi F, Garavand A. A copmarative review of electronic prescription systems: lessons learned from developed countries. J Res Pharm Pract. 2017;6(1):3–11.
doi: 10.4103/2279-042X.200993
pubmed: 28331859
pmcid: 5348854
Jebraeily M, Rashidi A, Mohitmafi T, Muossazadeh R. Evaluation of Outpatient Electronic prescription system capabilities from the perspective of Physicians in Specialized Polyclinics of Urmia Social Security Organization. Payavard Salamat. 2021;14(6):557–68.
Romanow D, Rai A, Keil M. CPOE-enabled coordination: appropriation for deep structure use and impacts on patient outcomes. MIS Q. 2018;42(1):189–212.
doi: 10.25300/MISQ/2018/13275
Motulsky A, Sicotte C, Gagnon MP, Payne-Gagnon J, Langué-Dubé JA, Rochefort CM, Tamblyn R. Challenges to the implementation of a nationwide electronic prescribing network in primary care: a qualitative study of users’ perceptions. J Am Med Inf Assoc. 2015;22(4):838–48.
doi: 10.1093/jamia/ocv026
Vermeulen KM, van Doormaal JE, Zaal RJ, Mol PGM, Lenderink AW, Haaijer-Ruskamp FM, et al. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients. Int J Med Inf. 2014;83(8):572–80.
doi: 10.1016/j.ijmedinf.2014.05.003
Subramanian S, Hoover S, Gilman B, Field TS, Mutter R, Gurwitz JH. Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc. 2007;55(9):1451–7.
doi: 10.1111/j.1532-5415.2007.01304.x
pubmed: 17915344
Van Laere S, Cornu P, Buyl R. A cross-sectional study of the Belgian community pharmacist’s satisfaction with the implementation of the electronic prescription. Int J Med Inf. 2020;135:104069.
doi: 10.1016/j.ijmedinf.2019.104069
Crosson JC, Etz RS, Wu S, Straus SG, Eisenman D, Bell DS. Meaningful use of electronic prescribing in 5 exemplar primary care practices. Ann Fam Med. 2011;9(5):392–7.
doi: 10.1370/afm.1261
pubmed: 21911757
pmcid: 3185481
Salmon JW, Jiang R. E-prescribing: history, issues, and potentials. Online J Public Health Inf. 2012;4(3).
Al-Kofahi MK, Hassan H, Mohamad R, Intan T, Com M. Information systems success model: a review of literature. Int J Innov Creativity Chang. 2020;12(8).
Akinyemi I, Schatz D, Bashroush R. SWOT analysis of information security management system ISO 27001. Int J Serv Oper Inf. 2020;10(4):305–29.
Shahmoradi L, Darrudi A, Arji G, Nejad AF. Electronic health record implementation: a SWOT analysis. Acta Med Iran. 2017:642–9.
Doshmangir L, Esmaeil Zadeh H, Arab Z. Assessing the strategic position of telemedicine technology in Iran. J Manag Med Inf Sci. 2015;2(2):144–51.
Khan IU, Yu Y, Hameed Z, Khan SU, Waheed A. Assessing the physicians’ acceptance of E-prescribing in a developing country: an extension of the UTAUT model with moderating effect of perceived organizational support. J Glob Inf Manag. 2018;26(3):121–42.
doi: 10.4018/JGIM.2018070109
Odenbach-Wanner S. Stakeholder-analysis of the effects on the health care system in terms of digitization and introduction of the e-prescription in Germany. Sci Int Empir Rev. 2024;2(1):1–28.
Watcharapinchai W, Sillabutra J, Soontornpipit P, Chootrakool H. Electronic-prescribing-system Protocol Development for Government Sector outpatients and Private Drug Stores: Case Study in Kalasin Province, Thailand. Thai J Public Health. 2022;52(3):222–40.
Alinejhad A, Nourani A, Jebraeily M. Usability evaluation of the user interface in electronic prescribing systems of Iran Health Insurance Organization and Social Security Organization. J Health Adm. 2022;25(2).
Alipour J, Sharifian R, Dehghan Haghighi J, Hashemzehi M, Karimi A. Patients’ perceptions, experiences, and satisfaction with e-prescribing system: a cross-sectional study. Int J Med Inf. 2023:105282.
Samadbeik M, Ahmadi M, Sadoughi F, Garavand A. Main elements of national model of electronic prescription system from physicians’ point of view: a case study in a developing country. Iran J Pharm Res. 2019;18(4):2204.
pubmed: 32184885
pmcid: 7059044
Hayavi-Haghighi MH, Davoodi S, Teshnizi SH, Jookar R. Usability evaluation of electronic prescribing systems from physicians’ perspective: a case study from southern Iran. Inf Med Unlocked. 2024;45:101460.
doi: 10.1016/j.imu.2024.101460
Raeesi A, Abbasi R, Khajouei R. Evaluating physicians’ perspectives on the efficiency and effectiveness of the electronic prescribing system. Int J Technol Assess Health Care. 2021;37(1):e42.
doi: 10.1017/S0266462321000052
pubmed: 33622433
Alinejhad A, Nourani A, Jebraeily M. Usability evaluation of the user interface in electronic prescribing systems of Iran health insurance organization and social security organization. J Health Adm. 2022;25(2):78–94.
Phadermrod B, Crowder RM, Wills GB. Importance-performance analysis based SWOT analysis. Int J Inf Manage. 2019;44:194–203.
doi: 10.1016/j.ijinfomgt.2016.03.009
van Wijngaarden JD, Scholten GR, van Wijk KP. Strategic analysis for health care organizations: the suitability of the SWOT-analysis. Int J Health Plann Manage. 2012;27(1):34–49.
doi: 10.1002/hpm.1032
pubmed: 20603842
Mwita K. Factors influencing data saturation in qualitative studies. Int J Res Bus Social Sci. 2022;11(4):414–20.
Olyaeemanesh A, Behzadifar M, Mousavinejhad N, Behzadifar M, Heydarvand S, Azari S, et al. Iran’s health system transformation plan: a SWOT analysis. Med J Islam Repub Iran. 2018;32:39.
doi: 10.14196/mjiri.32.39
pubmed: 30159290
pmcid: 6108248
Miller RA, Gardner RM, Johnson KB, Hripcsak G. Clinical decision support and electronic prescribing systems: a time for responsible thought and action. J Am Med Inf Assoc. 2005;12(4):403–9.
doi: 10.1197/jamia.M1830
Griffon N, Schuers M, Joulakian M, Bubenheim M, Leroy J-P, Darmoni SJ. Physician satisfaction with transition from CPOE to paper-based prescription. Int J Med Inf. 2017;103:42–8.
doi: 10.1016/j.ijmedinf.2017.04.007
Lyons AM, Sward KA, Deshmukh VG, Pett MA, Donaldson GW, Turnbull J. Impact of computerized provider order entry (CPOE) on length of stay and mortality. J Am Med Inf Assoc. 2017;24(2):303–9.
doi: 10.1093/jamia/ocw091
Kruse CS, Goetz K. Summary and frequency of barriers to adoption of CPOE in the U.S. J Med Syst. 2015;39(2):15.
doi: 10.1007/s10916-015-0198-2
pubmed: 25638719
pmcid: 4312581
Holden RJ. Physicians’ beliefs about using EMR and CPOE: in pursuit of a contextualized understanding of health IT use behavior. Int J Med Inf. 2010;79(2):71–80.
doi: 10.1016/j.ijmedinf.2009.12.003
Zadeh PE, Tremblay MC. A review of the literature and proposed classification on e-prescribing: functions, assimilation stages, benefits, concerns, and risks. Res Social Adm Pharm. 2016;12(1):1–19.
doi: 10.1016/j.sapharm.2015.03.001
Alipour J, Payandeh A, Hashemi A, Aliabadi A, Karimi A. Physicians’ perspectives with the E-prescribing system in five teaching hospitals. Appl Clin Inf. 2024;15(03):428–36.
doi: 10.1055/s-0044-1786872
Bulut S, Yıldız A, Kaya S. Evaluation of transition to electronic prescriptions in Turkey: perspective of family physicians. Int J Health Policy Manage. 2019;8(1):40.
doi: 10.15171/ijhpm.2018.89